Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells

Endocrinology

Volumn 147, Issue 1, 2006, Pages 222-231

  Goldberg, Howard J ^a,b   Whiteside, Catharine I ^a,b   Hart, Gerald W ^d   Fantus, I George ^a,b,c,e  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b Banting and Best Diabetes Centre   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLGLUCOSAMINIDASE; CARBAMIC ACID DERIVATIVE; ENZYME INHIBITOR; GLUCOSE; MESSENGER RNA; N ACETYLGLUCOSAMINYLTRANSFERASE; O (2 ACETAMIDO 2 DEOXY DETXRO GLUCOPYRANOSYLIDENE)AMINO N PHENYLCARBAMIC ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GLOMERULUS; GLYCOSYLATION; MESANGIUM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN PROCESSING; RAT; REPORTER GENE; RNA INTERFERENCE; TRANSCRIPTION INITIATION;

EID: 29344459211     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-0523     Document Type: Article

References (50)

1. The Diabetes Control and Complications Trial Research Group 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
2. Brownlee M 2001 Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820
3. Sheetz MJ, King GL 2002 Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288:2579-2588
4. Zachara NE, Hart GW 2004 O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim Biophys Acta 1673:13-28
5. McClain DA 2002 Hexosamines as mediators of nutrient sensing and regulation in diabetes. J Diabetic Compl 16:72-80
6. Boehmelt G, Wakeham A, Elia A, Sasaki T, Plyte S, Potter J, Yang Y, Tsang E, Ruland J, Iscove NN, Dennis JW, Mak TW 2000 Decreased UDP-GlcNAc levels abrogate proliferation control in EMeg32-deficient cells. EMBO J 19:5092-5104
7. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M 2000 Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 97:12222-12226
8. Du XL, Edelstein D, Dimmeler S, Ju O, Sui C, Brownlee M 2001 Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108:1341-1348
9. Kolm-Litty V, Sauer U, Nerlich A, Lehmann R, Schleicher ED 1998 High glucose-induced transforming growth factor β1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 101:160-169
10. Burt DJ, Gruden G, Thomas SM, Tutt P, Dell'Anna C, Viberti GC, Gnudi L 2003 P38 mitogen-activated protein kinase mediates hexosamine-induced TGFβ1 mRNA expression in human mesangial cells. Diabetologia 46:531-537
11. Sayeski PP, Kudlow JE 1996 Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-α gene transcription. J Biol Chem 271:15237-15243
12. Han I, Oh ES, Kudlow JE 2000 Responsiveness of the state of O-linked N-acetylglucosamine modification of nuclear pore protein p62 to the extracellular glucose concentration. Biochem J 350:109-114
13. Marshall S, Bacote V, Traxinger RR 1991 Discovery of a metabolic pathway mediating glucose-induced densenitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266:4706-4712
14. Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L 1998 A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 393:684-688
15. Vosseller K, Wells L, Lane MD, Hart, GW 2002 Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 99:5313-5318
16. McClain DA, Lubas WA, Cooksey RC, Hazel M, Parker GJ, Love DC, Hanover JA 2002 Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc Natl Acad Sci USA 99:10695-10699
17. Obici S, Wang J, Chowdury R, Feng Z, Siddhanta U, Morgan K, Rossetti L 2002 Identification of a biochemical link between energy intake and energy expenditure. J Clin Invest 109:1599-1605
18. Einstein FH, Atzmon G, Yang XM, Ma XH, Rincon M, Rudin E, Muzumdar R, Barzilai N 2005 Differential responses of visceral and subcutaneous fat depots to nutrients. Diabetes 54:672-678
19. Goldberg HJ, Scholey J, Fantus IG 2000 Glucosamine activates the plasminogen activator-inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. Diabetes 49:863-871
20. Singh LP, CrookED2000 Hexosamine regulation of glucose-mediated laminin synthesis in mesangial cells involves protein kinases A and C. Am J Physiol 279:F646-F654
21. James LR, Fantus IG, Goldberg H, Ly H, Scholey JW 2000 Overexpression of glutamine:fructose-6-phosphate amidotransferase (GFAT) activates PAI promoter. Am J Physiol 279:F718-F727
22. Goldberg HJ, Whiteside CI, Fantus IG 2002 The hexosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Sp1 transcriptional activation through protein kinase C-β I and -δ. J Biol Chem 277:33833-33841
23. Weigert C, Brodbeck K, Sawadogo M, Haring HU, Schleicher ED 2004 Upstream stimulatory factor (USF) proteins induce human TGF-β1 gene activation via the glucose-response element-1013/-1002 in mesangial cells: upregulation of USF activity by the hexosamine biosynthetic pathway. J Biol Chem 279:15908-15915
24. Steffes MW, Bilous RW, Sutherland DE, Mauer SM 1992 Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes 41:679-684
25. Zhang F, Su K, Yang X, Bowe DB, Paterson AJ, Kudlow JE 2003 O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115:715-725
26. Kreppel LK, Blomberg MA, Hart GW 1997 Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J Biol Chem 272:9308-9315
27. Lubas WA, Frank DW, Krause M, Hanover JA 1997 O-linked GlcNac transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats. J Biol Chem 272:9316-9324
28. Wells L, Gao Y, Mahoney JA, Vosseller K, Chen C, Rosen A, Hart GW 2002 Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic β-N-acetylglucosaminidase, O-GlcNAcase. J Biol Chem 277:1755-1761
29. James LR, Tang D, Ingram A, Ly H, Thai K, Cai L, Scholey JW 2002 Flux through the hexosamine pathway is a determinant of nuclear factor κB-dependent promoter activation. Diabetes 51:1146-1155
30. Kaneto H, Xu G, Song KH, Suzuma K, Bonner-Weir S, Sharma A, Weir GC 2001 Activation of the hexosamine pathway leads to deterioration of pancreatic β-cell function through the induction of oxidative stress. J Biol Chem 276:31099-31104
31. Wu G, Haynes TE, Li H, Yan, Meininger, CJ 2001 Glutamine metabolism to glucosamine is necessary for glutamine inhibition of endothelial nitric oxide synthesis. Biochem J 353:245-252
32. Partridge EA, Le Roy C, Di Guglielmo GM, Pawling J, Cheung P, Granovsky M, Nabi IR, Wrana JL, Dennis JW 2004 Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 306:120-124
33. Marshall S, Nadeau O, Yamasaki K 2005 Glucosamine-induced activation of glycogen biosynthesis in isolated adipocytes. Evidence for a rapid allosteric control mechanism within the hexosamine biosynthesis pathway. J Biol Chem 280:11018-11024
34. Masson E, Wiernsperger N, Lagarde M, El Bawab S 2005 Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides. Biochem J 388:537-544
35. Eddy AA 2002 Plasminogen activator inhibitor-1 and the kidney. Am J Physiol 283:F209-F220
36. Paueksakon P, Revelo MP, Ma LJ, Marcantoni C, Fogo AB 2002 Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy. Kidney Int 61:2142-2148
37. Tan J, Yang HS, Patel MS 1998 Regulation of mammalian pyruvate dehydrogenase α subunit gene expression by glucose in HepG2 cells. Biochem J 336:49-56
38. Love DC, Kochran J, Cathey RL, Shin, SH, Hanover JA 2002 Mitochondrial and nucleocytoplasmic targeting of O-linked GlcNAc transferase. J Cell Sci 116:647-654
39. Tseng TS, Swain SM, Olszewski NE 2001 Ectopic expression of the tetratricopeptide repeat domain of SPINDLY causes defects in gibberellin response. Plant Physiol 126:1250-1258
40. Semizarov, D, Frost L, Sarthy A, Kroeger P, Halbert DN, Fesik SW 2003 Specificity of short interfering RNA determined through gene expression signatures. Proc Natl Acad Sci USA 100:6347- 6352.
41. Majumdar G, Harmon A, Candelaria R, Martinez-Hernandez A, Raghow R, Solomon SS 2003 O-glycosylation of Sp1 and transcriptional regulation of the calmodulin gene by insulin and glucagon. Am J Physiol 285:E584-E591
42. Brasse-Lagnel C, Fairand A, Lavoinne A, Husson A 2003 Glutamine stimulates argininosuccinate synthetase gene expression through cytosolic O-glycosylation of Sp1 in Caco-2 cells. J Biol Chem 278:52504-52510
43. Weigert C, Klopfer K, Kausch C, Brodbeck K, Stumvoll M, Haring HU, Schleicher ED 2003 Palmitate-induced activation of the hexosamine pathway in human myotubes: increased expression of glutamine:fructose-6-phosphate aminotransferase. Diabetes 52:650-656
44. Haltiwanger RS, Grove K, Philipsberg GA 1998 Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-β-N-acetylglucosaminidase inhibitor O-(2-Acetoamido-2- deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate. J Biol Chem 273:3611-3617
45. Yang X, Su K, Roos MD, Chang Q, Paterson AJ, Kudlow JE 2001 O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc Natl Acad Sci USA 98:6611-6616
46. Yang X, Zhang F, Kudlow JE 2002 Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression. Cell 110:69-80
47. Singh LP, Green K, Alexander M, Bassly S, Crook ED 2004 Hexosamines and TGF-β1 use similar signaling pathways to mediate matrix protein synthesis in mesangial cells. Am J Physiol 286:F409-F416
48. Gewinner C, Hart G, Zachara N, Cole R, Beisenherz-Huss C, Groner B 2003 The coactivator of transcription CREB binding protein interacts preferentially with the glycosylated form of Stat5. J Biol Chem 279:3563-3572
49. Hsieh TJ, Fustier P, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Fantus IG, Hamet P, Chan JS 2003 High glucose stimulates angiotensinogen gene expression and cell hypertrophy via activation of the hexosamine biosynthesis pathway in rat kidney proximal tubular cells. Endocrinology 144:4338-4349
50. Kneass ZT, Marchase RB 2005 Protein O-GlcNAc modulates motility-associated signaling intermediates in neutrophils. J Biol Chem 280:14579-14585